.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Accenture
US Army
Fuji
Cipla
Dow
Mallinckrodt
Argus Health
Covington
Baxter

Generated: November 23, 2017

DrugPatentWatch Database Preview

Aralez Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for ARALEZ PHARMS, and when can generic versions of ARALEZ PHARMS drugs launch?

ARALEZ PHARMS has four approved drugs.

There are ten US patents protecting ARALEZ PHARMS drugs on ARALEZ PHARMS drugs in the past three years.

There are one hundred and ninety-three patent family members on ARALEZ PHARMS drugs in forty countries and twenty-one supplementary protection certificates in fourteen countries.

Summary for Aralez Pharms

International Patents:193
US Patents:10
Tradenames:4
Ingredients:4
NDAs:4
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aralez Pharms
TOPROL-XL
metoprolol succinate
TABLET, EXTENDED RELEASE;ORAL019962-004Feb 5, 2001ABRXYesNo► Subscribe► Subscribe► Subscribe
Aralez Pharms Inc
FIBRICOR
fenofibric acid
TABLET;ORAL022418-002Aug 14, 2009RXYesYes► Subscribe► Subscribe ► Subscribe
Aralez Pharms Inc
FIBRICOR
fenofibric acid
TABLET;ORAL022418-002Aug 14, 2009RXYesYes► Subscribe► Subscribe ► Subscribe
Aralez Pharms
ZONTIVITY
vorapaxar sulfate
TABLET;ORAL204886-001May 8, 2014RXYesYes► Subscribe► Subscribe► Subscribe
Aralez Pharms Inc
FIBRICOR
fenofibric acid
TABLET;ORAL022418-001Aug 14, 2009RXYesNo► Subscribe► Subscribe ► Subscribe
Aralez Pharms
YOSPRALA
aspirin; omeprazole
TABLET, DELAYED RELEASE;ORAL205103-001Sep 14, 2016RXYesNo► Subscribe► Subscribe ► Subscribe
Aralez Pharms
ZONTIVITY
vorapaxar sulfate
TABLET;ORAL204886-001May 8, 2014RXYesYes► Subscribe► SubscribeYY ► Subscribe
Aralez Pharms
TOPROL-XL
metoprolol succinate
TABLET, EXTENDED RELEASE;ORAL019962-002Jan 10, 1992ABRXYesNo► Subscribe► Subscribe► Subscribe
Aralez Pharms
YOSPRALA
aspirin; omeprazole
TABLET, DELAYED RELEASE;ORAL205103-002Sep 14, 2016RXYesYes► Subscribe► Subscribe ► Subscribe
Aralez Pharms
ZONTIVITY
vorapaxar sulfate
TABLET;ORAL204886-001May 8, 2014RXYesYes► Subscribe► SubscribeYY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Aralez Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Aralez Pharms
TOPROL-XL
metoprolol succinate
TABLET, EXTENDED RELEASE;ORAL019962-002Jan 10, 1992► Subscribe► Subscribe
Aralez Pharms
TOPROL-XL
metoprolol succinate
TABLET, EXTENDED RELEASE;ORAL019962-002Jan 10, 1992► Subscribe► Subscribe
Aralez Pharms
TOPROL-XL
metoprolol succinate
TABLET, EXTENDED RELEASE;ORAL019962-001Jan 10, 1992► Subscribe► Subscribe
Aralez Pharms
TOPROL-XL
metoprolol succinate
TABLET, EXTENDED RELEASE;ORAL019962-004Feb 5, 2001► Subscribe► Subscribe
Aralez Pharms
TOPROL-XL
metoprolol succinate
TABLET, EXTENDED RELEASE;ORAL019962-003Jan 10, 1992► Subscribe► Subscribe
Aralez Pharms
TOPROL-XL
metoprolol succinate
TABLET, EXTENDED RELEASE;ORAL019962-003Jan 10, 1992► Subscribe► Subscribe
Aralez Pharms
TOPROL-XL
metoprolol succinate
TABLET, EXTENDED RELEASE;ORAL019962-004Feb 5, 2001► Subscribe► Subscribe
Aralez Pharms
TOPROL-XL
metoprolol succinate
TABLET, EXTENDED RELEASE;ORAL019962-004Feb 5, 2001► Subscribe► Subscribe
Aralez Pharms
TOPROL-XL
metoprolol succinate
TABLET, EXTENDED RELEASE;ORAL019962-002Jan 10, 1992► Subscribe► Subscribe
Aralez Pharms
TOPROL-XL
metoprolol succinate
TABLET, EXTENDED RELEASE;ORAL019962-003Jan 10, 1992► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for ARALEZ PHARMS drugs

Drugname Dosage Strength Tradename Submissiondate
aspirin and omeprazole
Delayed-release Tablets81 mg/40 mg
YOSPRALA
10/14/2016

Non-Orange Book Patents for Aralez Pharms

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,488,742Thrombin receptor antagonists► Subscribe
6,894,065 Thrombin receptor antagonists► Subscribe
8,557,285Pharmaceutical compositions for the coordinated delivery of NSAIDs► Subscribe
8,865,190Pharmaceutical compositions for the coordinated delivery of NSAIDs► Subscribe
9,161,920Pharmaceutical compositions for the coordinated delivery of NSAIDs► Subscribe
9,345,695Pharmaceutical compositions for the coordinated delivery of NSAIDs► Subscribe
9,220,698Method for delivering a pharmaceutical composition to patient in need thereof► Subscribe
9,393,208Method for delivering a pharmaceutical composition to patient in need thereof► Subscribe
6,645,987 Nor-seco himbacine derivatives useful as thrombin receptor antagonists► Subscribe
9,707,181Pharmaceutical compositions for the coordinated delivery of NSAIDs► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Aralez Pharms Drugs

Country Document Number Estimated Expiration
China101899039► Subscribe
World Intellectual Property Organization (WIPO)03089428► Subscribe
China1659162► Subscribe
Denmark1495018► Subscribe
New Zealand548156► Subscribe
Japan2004503551► Subscribe
Portugal1294714► Subscribe
Tunisia2011000096► Subscribe
South Korea101039973► Subscribe
Singapore147466► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Aralez Pharms Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0150025 00159Estonia► SubscribePRODUCT NAME: VORAPAKSAAR;REG NO/DATE: EU/1/14/976 21.01.2015
C0047France► SubscribePRODUCT NAME: VORAPAXAR,OU L'UN DE SES SELS OU SOLVATES PHARMACEUTIQUEMENT ACCEPTABLES; REGISTRATION NO/DATE: EU/1/14/976/001-006 20150121
0746Netherlands► SubscribePRODUCT NAME: VORAPAXAR, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT OF SOLVAAT, IN HET BIJZONDER VORAPAXARSULFAAT; REGISTRATION NO/DATE: EU/1/14/976/001-006 20150121
858Luxembourg► Subscribe91858, EXPIRES: 20251105
500036Hungary► SubscribePRODUCT NAME: VORAPAXAR; REGISTRATION NO/DATE: EU/1/14/976 20150119
2015 00037Denmark► SubscribePRODUCT NAME: VORAPAXAR, OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF, INCLUDING VORAPAXARSULPHATE; REG. NO/DATE: EU/1/14/976/001-06 20150119
1411900/01Switzerland► SubscribePRODUCT NAME: ESOMEPRAZOL + NAPROXEN; REGISTRATION NO/DATE: SWISSMEDIC 61330 06.05.2011
90037-6Sweden► SubscribePRODUCT NAME: VORAPAXAR, OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF; REG. NO/DATE: EU/1/14/976/001 20150121
2012 00036Denmark► Subscribe
2015 00037Denmark► SubscribePRODUCT NAME: VORAPAXAR, OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF, INCLUDING VORAPAXARSULPHATE; REG. NO/DATE: EU/1/14/976/001-06 20150119
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Fish and Richardson
Merck
Julphar
Chinese Patent Office
Baxter
US Department of Justice
Argus Health
Farmers Insurance
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot